ACHV

Achieve Life Sciences, Inc.

NASDAQHealthcareBiotechnologyCA

USD4.92

-0.11 (-2.19%)

Rating:C-

Company Profile

CEO

Richard A. Stewart

IPO Date

1995-10-12

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$4.95

Prev. Close

$5.03

Day Low

$4.71

Day High

$5.00

52W Low

$2.00

52W High

$6.15

Market Cap

$0.51B

Volume

1.36M

News SentimentBullish

Articles

Avg Positive

34.7%

Avg Negative

2.9%

Avg Neutral

62.5%

News Feed

Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use

Accesswire·7/22/2021·↑ positive

Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline

Accesswire·6/29/2021·↑ positive

Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction

Accesswire·6/3/2021·↑ positive

Achieve Life Sciences to Present at LD Micro Invitational XI Virtual Conference